UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13
OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September
30, 2023
or
☐ TRANSITION REPORT PURSUANT TO SECTION 13
OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
FinServ Acquisition Corp. II
(Exact name of registrant as specified in its charter)
Delaware | | 001-40076 | | 85-4030806 |
(State or other jurisdiction
of incorporation) | | (Commission File Number) | | (IRS Employer
Identification No.) |
c/o Ellenoff Grossman & Schole LLP
1345 Avenue of the Americas
New York, NY 10105
(Address of principal executive offices, including
zip code)
Registrant’s telephone number, including
area code: (929) 529-7125
Not Applicable
(Former name or former address, if changed since
last report)
Securities registered pursuant to Section 12(b)
of the Act:
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
Units, each consisting of one share of Class A Common Stock and one-quarter of one Redeemable Warrant | | FSRXU | | The Nasdaq Stock Market LLC |
Class A Common Stock, par value $0.0001 per share | | FSRX | | The Nasdaq Stock Market LLC |
Warrants, each exercisable for one share of Class A Common Stock for $11.50 per share | | FSRXW | | The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant
has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§
232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes ☒ No ☐
Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.
See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,”
and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☐ | Accelerated filer | ☐ |
Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
Emerging growth company | ☒ | | |
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant
is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐
As of November 13,
2023, there were 9,338,154 shares of Class A common stock, par value $0.0001 per share and one share of the Company’s Class B common
stock, par value $0.0001 per share, of the registrant issued and outstanding.
FINSERV ACQUISITION CORP. II
Quarterly Report on Form 10-Q
Table of Contents
PART I - FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
FINSERV ACQUISITION CORP. II
CONDENSED BALANCE SHEETS
| |
September 30, 2023 | | |
December 31, 2022 | |
| |
(Unaudited) | | |
| |
Assets: | |
| | |
| |
Current Assets: | |
| | |
| |
Cash | |
$ | 84,617 | | |
$ | 61,264 | |
Investments in mutual funds | |
| 47,663 | | |
| 549,408 | |
Prepaid expenses | |
| 135,343 | | |
| 31,621 | |
Total current assets | |
| 267,623 | | |
| 642,293 | |
| |
| | | |
| | |
Cash held in Trust Account | |
| 10,722,779 | | |
| — | |
Cash and investments held in Trust Account | |
| — | | |
| 303,511,593 | |
Total assets | |
$ | 10,990,402 | | |
$ | 304,153,886 | |
| |
| | | |
| | |
Liabilities, Redeemable Common Stock and Stockholders’ Deficit | |
| | | |
| | |
Current liabilities: | |
| | | |
| | |
Accounts payable and accrued expenses | |
$ | 55,366 | | |
$ | 46,696 | |
Income tax payable | |
| 13,924 | | |
| 401,562 | |
Excise tax payable | |
| 2,944,996 | | |
| — | |
Promissory Note to related party | |
| 125,000 | | |
| — | |
Total current liabilities | |
| 3,139,286 | | |
| 448,258 | |
Warrant liability | |
| 232,540 | | |
| 77,000 | |
Deferred liabilities | |
| 83,396 | | |
| 18,992 | |
Deferred underwriting fee | |
| 10,500,000 | | |
| 10,500,000 | |
Total liabilities | |
| 13,955,222 | | |
| 11,044,250 | |
| |
| | | |
| | |
Commitments and Contingencies (Note 6) | |
| | | |
| | |
Common Stock subject to possible redemption, 1,038,155 shares and 30,000,000 shares at approximately $10.26 and $10.11 redemption value at September 30, 2023 and December 31, 2022, respectively | |
| 10,656,367 | | |
| 303,211,829 | |
| |
| | | |
| | |
Stockholders’ Deficit: | |
| | | |
| | |
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding at September 30, 2023 and December 31, 2022 | |
| — | | |
| — | |
Class A common stock, $0.0001 par value; 100,000,000 shares authorized; 8,299,999 and 800,000 shares issued and outstanding (excluding 1,038,155 shares and 30,000,000 shares subject to possible redemption) at September 30, 2023 and December 31, 2022, respectively | |
| 830 | | |
| 80 | |
Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 1 and 7,500,000 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively | |
| — | | |
| 750 | |
Additional paid-in capital | |
| — | | |
| — | |
Accumulated deficit | |
| (13,622,017 | ) | |
| (10,103,023 | ) |
Total stockholders’ deficit | |
| (13,621,187 | ) | |
| (10,102,193 | ) |
Total Liabilities, Redeemable Common Stock and Stockholders’ Deficit | |
$ | 10,990,402 | | |
$ | 304,153,886 | |
The accompanying notes are an integral part of
these unaudited condensed financial statements.
FINSERV ACQUISITION CORP. II
UNAUDITED CONDENSED STATEMENTS OF OPERATIONS
| |
For the Three Months Ended September 30, | | |
For the Nine Months Ended September 30, | |
| |
2023 | | |
2022 | | |
2023 | | |
2022 | |
Formation and operating costs | |
$ | 202,530 | | |
$ | 211,809 | | |
$ | 795,060 | | |
$ | 612,419 | |
Loss from operations | |
| (202,530 | ) | |
| (211,809 | ) | |
| (795,060 | ) | |
| (612,419 | ) |
Other income: | |
| | | |
| | | |
| | | |
| | |
Interest earned on marketable securities held in Trust Account | |
| 327,077 | | |
| 1,323,260 | | |
| 2,911,687 | | |
| 1,731,082 | |
Change in fair value of warrant liability | |
| (43,120 | ) | |
| 1,001,000 | | |
| (155,540 | ) | |
| 4,543,000 | |
Income (loss) on investments in mutual funds | |
| 1,105 | | |
| 289 | | |
| 15,444 | | |
| (31,939 | ) |
Total other income, net | |
| 285,062 | | |
| 2,324,549 | | |
| 2,771,591 | | |
| 6,242,143 | |
| |
| | | |
| | | |
| | | |
| | |
Income before provision for income taxes | |
| 82,532 | | |
| 2,112,740 | | |
| 1,976,531 | | |
| 5,629,724 | |
Provision for income taxes | |
| (78,830 | ) | |
| (267,445 | ) | |
| (606,362 | ) | |
| (291,180 | ) |
Net income | |
$ | 3,702 | | |
$ | 1,845,295 | | |
$ | 1,370,169 | | |
$ | 5,338,544 | |
Basic and diluted weighted average shares outstanding, redeemable Class A common stock | |
| 3,296,904 | | |
| 30,000,000 | | |
| 9,076,870 | | |
| 30,000,000 | |
Basic and diluted net income per share, redeemable Class A common stock | |
$ | 0.00 | | |
$ | 0.05 | | |
$ | 0.08 | | |
$ | 0.14 | |
Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B common stock | |
| 8,300,000 | | |
| 8,300,000 | | |
| 8,300,000 | | |
| 8,300,000 | |
Basic and diluted net income per share, non-redeemable Class A and Class B common stock | |
$ | 0.00 | | |
$ | 0.05 | | |
$ | 0.08 | | |
$ | 0.14 | |
The accompanying notes are an integral part of
these unaudited condensed financial statements.
FINSERV ACQUISITION CORP. II
UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER
30, 2023
| |
Class A Common Stock | | |
Class B Common Stock | | |
Additional Paid-in | | |
Accumulated | | |
Total Stockholders’ | |
| |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Capital | | |
Deficit | | |
Deficit | |
Balance as of January 1, 2023 | |
| 800,000 | | |
$ | 80 | | |
| 7,500,000 | | |
$ | 750 | | |
$ | — | | |
$ | (10,103,023 | ) | |
$ | (10,102,193 | ) |
Conversion of Class B common stock to Class A common stock | |
| 7,499,999 | | |
| 750 | | |
| (7,499,999 | ) | |
| (750 | ) | |
| — | | |
| — | | |
| — | |
Accretion of Class A common stock subject to possible redemption | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (1,540,801 | ) | |
| (1,540,801 | ) |
Net income | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 1,049,325 | | |
| 1,049,325 | |
Balance as of March 31, 2023 (Unaudited) | |
| 8,299,999 | | |
| 830 | | |
| 1 | | |
| — | | |
| — | | |
| (10,594,499 | ) | |
| (10,593,669 | ) |
Excise tax on stock redemptions | |
| | | |
| | | |
| | | |
| | | |
| | | |
| (2,542,012 | ) | |
| (2,542,012 | ) |
Accretion of Class A common stock subject to possible redemption | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (188,920 | ) | |
| (188,920 | ) |
Net income | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 317,142 | | |
| 317,142 | |
Balance as of June 30, 2023 (Unaudited) | |
| 8,299,999 | | |
$ | 830 | | |
| 1 | | |
$ | — | | |
$ | — | | |
$ | (13,008,289 | ) | |
$ | (13,007,459 | ) |
Excise tax on stock redemptions | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (402,984 | ) | |
| (402,984 | ) |
Accretion of Class A common stock subject to possible redemption | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (214,446 | ) | |
| (214,446 | ) |
Net income | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 3,702 | | |
| 3,702 | |
Balance as of September 30, 2023 (Unaudited) | |
| 8,299,999 | | |
$ | 830 | | |
| 1 | | |
$ | — | | |
$ | — | | |
$ | (13,622,017 | ) | |
$ | (13,621,187 | ) |
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER
30, 2022
| |
Class A Common Stock | | |
Class B Common Stock | | |
Additional Paid-in | | |
Accumulated | | |
Stockholders’ | |
| |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Capital | | |
Deficit | | |
Deficit | |
Balance as of January 1, 2022 | |
| 800,000 | | |
$ | 80 | | |
| 7,500,000 | | |
$ | 750 | | |
$ | — | | |
$ | (14,167,989 | ) | |
$ | (14,167,159 | ) |
Net income | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 2,122,606 | | |
| 2,122,606 | |
Balance as of March 31, 2022 | |
| 800,000 | | |
$ | 80 | | |
| 7,500,000 | | |
| 750 | | |
| — | | |
| (12,045,383 | ) | |
| (12,044,553 | ) |
Accretion of Class A common stock subject to possible redemption | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (123,481 | ) | |
| (123,481 | ) |
Net income | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 1,370,643 | | |
| 1,370,643 | |
Balance as of June 30, 2022 | |
| 800,000 | | |
$ | 80 | | |
| 7,500,000 | | |
$ | 750 | | |
$ | — | | |
$ | (10,798,221 | ) | |
$ | (10,797,391 | ) |
Accretion of Class A common stock subject to possible redemption | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (1,006,265 | ) | |
| (1,006,265 | ) |
Net income | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 1,845,295 | | |
| 1,845,295 | |
Balance as of September 30, 2022 | |
| 800,000 | | |
$ | 80 | | |
| 7,500,000 | | |
$ | 750 | | |
$ | — | | |
$ | (9,959,191 | ) | |
$ | (9,958,361 | ) |
The accompanying notes are an integral part of
these unaudited condensed financial statements.
FINSERV ACQUISITION CORP. II
UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS
| |
For the Nine Months Ended
September 30, | |
| |
2023 | | |
2022 | |
Cash flows from Operating Activities: | |
| | |
| |
Net income | |
$ | 1,370,169 | | |
$ | 5,338,544 | |
Adjustments to reconcile net income to net cash used in operating activities: | |
| | | |
| | |
Interest earned on marketable securities held in Trust Account | |
| (2,911,687 | ) | |
| (1,731,082 | ) |
Loss on investment in mutual funds | |
| — | | |
| 31,939 | |
Change in fair value of warrant liability | |
| 155,540 | | |
| (4,543,000 | ) |
Change in deferred liabilities | |
| 64,404 | | |
| 11,449 | |
Changes in operating assets and liabilities: | |
| | | |
| | |
Prepaid expenses and other noncurrent assets | |
| (103,722 | ) | |
| 159,322 | |
Promissory Note to Related Party | |
| 125,000 | | |
| — | |
Income tax payable | |
| (387,638 | ) | |
| 219,180 | |
Accounts payable and accrued expenses | |
| 8,671 | | |
| (299,091 | ) |
Net cash used in operating activities | |
| (1,679,263 | ) | |
| (812,739 | ) |
| |
| | | |
| | |
Cash Flows from Investing Activities: | |
| | | |
| | |
Proceeds from sale of mutual funds | |
| — | | |
| 470,000 | |
Cash withdrawn to pay taxes | |
| 1,200,871 | | |
| 392,691 | |
Cash withdrawn in connection with redemption | |
| 294,500,735 | | |
| — | |
Net cash provided by investing activities | |
| 295,701,606 | | |
| 862,691 | |
| |
| | | |
| | |
Cash Flows from Financing Activity: | |
| | | |
| | |
Redemption of Class A common stock | |
| (294,500,735 | ) | |
| — | |
Net cash used in financing activity | |
| (294,500,735 | ) | |
| — | |
| |
| | | |
| | |
Net change in cash and cash equivalents | |
| (478,392 | ) | |
| 49,952 | |
Cash and cash equivalents, beginning of period | |
| 610,672 | | |
| 152,443 | |
Cash and cash equivalents, end of period | |
$ | 132,280 | | |
$ | 202,395 | |
Supplemental disclosure of cash flow information from financing activities: | |
| | | |
| | |
Cash paid for income taxes | |
$ | 944,000 | | |
$ | — | |
Excise tax payable on stock redemption | |
$ | 2,944,996 | | |
$ | — | |
The accompanying notes are an integral part of
these unaudited condensed financial statements.
FINSERV ACQUISITION CORP. II
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2023
Note 1 — Organization and Business Operations
FinServ Acquisition Corp. II (the “Company”)
is a blank check company incorporated as a Delaware corporation on November 23, 2020. The Company was formed for the purpose of effecting
a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses
(“Business Combination”).
As of September 30, 2023, the Company had not
commenced any operations. All activity through September 30, 2023 relates to the Company’s formation and the initial public offering
(“IPO”) which is described below, and, since the closing of the IPO, identifying a target company for a Business Combination.
The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company
generates non-operating income in the form of interest income from the proceeds derived from the IPO.
The registration statement for the Company’s
IPO (the “IPO Registration Statement”) was declared effective by the U.S. Securities and Exchange Commission (the “SEC”)
on February 17, 2021. On February 22, 2021, the Company consummated the IPO of 30,000,000 units (the “Units” and,
with respect to the shares of Class A common stock included in the Units sold, the “Public Shares,” and with respect to the
Warrants included in the Units sold, the “Public Warrants”), which included the partial exercise by the underwriters of the
over-allotment option resulting in the purchase of an additional 3,500,000 Units, at $10.00 per Unit, generating gross
proceeds of $300,000,000, which is discussed in Note 3. Each Unit consists of one share of Class A common stock, and one-fourth
of one redeemable Warrant to purchase one share of Class A common stock at a price of $11.50 per whole share.
Simultaneously with the closing of the IPO, the
Company consummated the sale of 800,000 placement units (the “Placement Units”), at a price of $10.00 per
Placement Unit, in a private placement (the “Private Placement”) to FinServ Holdings II LLC, a Delaware limited liability
company (the “Sponsor”), generating gross proceeds of $8,000,000, which is discussed in Note 4.
Transaction costs of the IPO amounted to $16,792,661,
consisting of $6,000,000 of underwriting discount, $10,500,000 of deferred underwriting discount, and $292,661 of other
offering costs. Total transaction costs included $457,600 of expenses associated with the warrant liability.
Following the closing of the IPO on February 22,
2021, $300,000,000 ($10.00 per Unit) from the net offering proceeds of the sale of the Units in the IPO and the sale of the
Placement Units was placed in a trust account (the “Trust Account”) and invested in U.S. government treasury bills with a
maturity of 185 days or less or in money market funds investing solely in U.S. Treasuries, as determined by the Company, until the earlier
of: (a) the completion of the Company’s initial Business Combination, (b) the redemption of any Public Shares properly
submitted in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation (i) to
modify the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination
or certain amendments to the charter prior thereto or to redeem 100% of the Public Shares if the Company does not complete the initial
Business Combination within 24 months from the closing of the IPO or (ii) with respect to any other provision relating to stockholders’
rights or pre-Business Combination activity, and (c) the redemption of the Public Shares if the Company is unable to complete
the initial Business Combination within 24 months from the closing of the IPO, subject to applicable law. The proceeds deposited
in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims
of the public stockholders.
The Company will provide its public stockholders
with the opportunity to redeem all or a portion of their Public Shares upon the completion of the initial Business Combination either
(i) in connection with a stockholder meeting called to approve the initial Business Combination or (ii) by means of a tender
offer. The decision as to whether the Company will seek stockholder approval of a proposed initial Business Combination or conduct a tender
offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction
and whether the terms of the transaction would require the Company to seek stockholder approval under the law or stock exchange listing
requirements. The stockholders will be entitled to redeem their shares for a pro rata share of the aggregate amount then on deposit in
the Trust Account (initially approximately $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account
and not previously released to the Company to pay its tax obligations.
On February 20, 2023, the Company held a special
meeting in lieu of the 2022 annual meeting of stockholders (the “First Extension Meeting”). At the First Extension Meeting,
the Company’s stockholders approved an amendment to the Company’s amended and restated certificate of incorporation (the “First
Extension Amendment”) to extend the date by which the Company must consummate its initial Business Combination from February 22,
2023 to August 22, 2023, or such earlier date as determined by the Company’s board of directors (the “Board”). In connection
with the First Extension Meeting, stockholders holding 25,040,997 shares of the Company’s Class A common stock issued in the Company’s
IPO exercised their right to redeem such shares for a pro rata portion of the funds in the Company’s Trust Account. As a result,
approximately $254,201,240 (approximately $10.15 per share) was removed from the Company’s Trust Account to pay such stockholders.
On August 18, 2023, the Company held another special
meeting of stockholders (the “Second Extension Meeting”). At the Second Extension Meeting, the Company’s stockholders
approved (1) an amendment to the Company’s amended and restated certificate of incorporation, as amended on February 21, 2023 (the
“Charter”), to extend the date by which the Company must consummate its Business Combination from August 22, 2023 to February
22, 2024 (or such earlier date as determined by the Board) (the “Second Extension Amendment”); and (2) an amendment to the
Charter to eliminate from the Charter the limitation that the Company will only redeem the Public Shares so long as (after such redemption),
the Company’s net tangible assets, or of any entity that succeeds to the Company as a public company, will be at least $5,000,001
either immediately prior to or upon consummation of the Business Combination (the “Redemption Limitation Amendment”). The
Company filed the Second Extension Amendment with the Secretary of State of the State of Delaware on August 18, 2023. The Company filed
the Redemption Limitation Amendment with the Secretary of State of the State of Delaware on August 23, 2023.
In connection with the Second Extension Meeting,
stockholders holding 3,920,848 Public Shares exercised their right to redeem their shares for a pro rata portion of the funds in the Trust
Account. As a result, approximately $40,298,391 (approximately $10.28 per Public Share) was removed from the Trust Account to pay such
holders and approximately $10,670,135 will remain in the Trust Account. Following redemptions, the Company has 9,338,154 shares of Class
A common stock outstanding.
Following the Second Extension Amendment, the
Company has until February 22, 2024, to complete an initial Business Combination (the “Combination Period”). However, if the
Company doesn’t complete a Business Combination within the Combination Period, the Company will (i) cease all operations except
for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public
Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest
earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes (less up to $100,000 of interest
to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public
stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly
as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Board,
liquidate and dissolve, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors
and the requirements of other applicable law.
The Sponsor, officers and directors have agreed
to (i) waive their redemption rights with respect to their Founder Shares (as defined below) and Public Shares in connection with
the completion of the initial Business Combination, (ii) waive their redemption rights with respect to their Founder Shares and Public
Shares in connection with a stockholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation
(A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with an initial Business
Combination or to redeem 100% of the Public Shares if the Company does not complete the initial Business Combination within the Combination
Period or (B) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination
activity, (iii) waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares if the
Company fails to complete the initial Business Combination within the Combination Period, although they will be entitled to liquidating
distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete the initial Business
Combination within the prescribed time frame, and (iv) vote any Founder Shares and placement shares held by them and any Public Shares
purchased during or after the IPO (including in open market and privately-negotiated transactions) in favor of the Company’s
initial Business Combination. “Founder Shares” shall mean the shares of Class B common stock purchased by the Sponsor in December
2020 and the shares of Class A common stock issued to the Sponsor upon conversion of the Class B common stock in January 2023.
The Company’s Sponsor has agreed that it
will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company,
or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement
or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share
and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, if
less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not
apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in
the Trust Account (whether or not such waiver is enforceable), nor will it apply to any claims under the Company’s indemnity of
the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities
Act”). However, the Company has not asked its Sponsor to reserve for such indemnification obligations, nor has the Company independently
verified whether its Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Company’s Sponsor’s
only assets are securities of the Company. Therefore, the Company cannot assure that its Sponsor would be able to satisfy those obligations.
Liquidity and Going Concern
As of September 30, 2023, the Company had approximately
$84,617 in its operating bank account and $ 47,663 in money market account and working capital deficit of $2,871,663.
In connection with the Company’s assessment
of going concern considerations in accordance with Financial Accounting Standard Board (“FASB”) Accounting Standards Update
(“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,”
the Company has until February 22, 2024, to consummate a Business Combination. It is uncertain whether the Company will be able to consummate
a Business Combination by this time. The Company also has incurred and expects to continue to incur significant costs in pursuit of its
financing and acquisition plans. If the Company’s estimates of the costs of identifying a target business, undertaking in-depth
due diligence, and negotiating a Business Combination are less than the actual amount necessary to do so, the Company may have insufficient
funds to operate its business prior to the date of business combination. If a Business Combination is not consummated by February
22, 2024, and if there are no further amendments to extend the date of the Business Combination beyond February 22, 2023, there will be
a mandatory liquidation and subsequent dissolution of the Company. Management will continue to search for a Business Combination, however,
there is no assurance the Company will find a suitable target. Management has determined that potential liquidity shortfall and mandatory
liquidation deadline raise substantial doubt about the Company’s ability to continue as a going concern.
Risks and Uncertainties
Management is continuing to evaluate the impacts
of the COVID-19 pandemic and the ongoing conflict in Ukraine and has concluded that while it is reasonably possible that these events
could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company,
the specific impact is not readily determinable as of the date of these unaudited condensed financial statements. The unaudited condensed
financial statements do not include any adjustments that might result from the outcome of these uncertainties.
Inflation Reduction Act of 2022
On August 16, 2022, the Inflation Reduction Act
of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1%
excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly
traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not
its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the
shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted
to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable
year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been
given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.
Any redemption or other repurchase that occurs
after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether
and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise
would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business
Combination, Extension or otherwise, (ii) the structure of the Business Combination, (iii) the nature and amount of any “PIPE”
or other equity issuances in connection with the Business Combination (or otherwise issued not in connection with the Business Combination
but issued within the same taxable year of the Business Combination) and (iv) the content of regulations and other guidance from the Treasury.
In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment
of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business
Combination and in the Company’s ability to complete a Business Combination.
As discussed above, on February 20, 2023, holders
of 25,040,997 shares of Common Stock elected to redeem their shares in connection with the Extension. As a result, $254,201,240 was
removed from the Company’s Trust Account to pay such holders. In connection with the Second Extension Meeting, stockholders holding
3,920,848 Public Shares exercised their right to redeem their shares for a pro rata portion of the funds in the Trust Account. As a result,
approximately $40,298,391 was removed from the Company’s Trust Account to pay such holders. Management has evaluated the requirements
of the IR Act and the Company’s operations at the end of the reporting period and has determined that a liability of $2,944,996
should be recorded for the excise tax in connection with the above-mentioned redemptions. This liability will be reviewed and remeasured
at each reporting period.
Note 2 — Significant Accounting Policies
Basis of Presentation
The accompanying unaudited condensed financial
statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”)
for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information
and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which
include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented.
The accompanying unaudited condensed financial
statements should be read in conjunction with the Company’s Form 10-K December 31, 2022 as filed with the SEC on March 31, 2023
which contains the audited financial statements and notes thereto. The interim results for the three and nine months ended September 30,
2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future interim periods.
Emerging Growth Company Status
The Company is an “emerging growth company,”
as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012, (the “JOBS Act”),
and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that
are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements
of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and
proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder
approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts
emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that
is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered
under the Securities Exchange Act of 1934, the “Exchange Act”) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.
Use of Estimates
The preparation of unaudited condensed financial
statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported
amounts of expenses during the reporting period. Accordingly, actual results could differ from those estimates.
Making estimates requires management to exercise
significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances
that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could
change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these
unaudited condensed financial statements is the determination of the fair value of the warrant liability. Accordingly, the actual results
could differ significantly from those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments
with an original maturity of three months or less when purchased to be cash equivalents. As of September 30, 2023 and December 31, 2022,
the Company had $132,280 and $610,672 of cash and cash equivalents, respectively.
Investments in Mutual Funds
At September 30, 2023 and December 31, 2022, the
Company had $47,663 and $549,408 invested in mutual funds. The estimated fair values of the mutual fund investments are determined using
available market information.
Investments Held in Trust Account
At September 30, 2023, the assets held in the
Trust Account were held in demand deposits. At December 31, 2022, the assets held in the Trust Account were held in money market funds
which invest in U.S. Treasury securities.
Concentration of Credit Risk
Financial instruments that potentially subject
the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal
Deposit Insurance Corporation coverage of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse
impact on the Company’s financial condition, results of operations, and cash flows.
Warrant Liabilities
The Company does not use derivative instruments
to hedge exposure to cash flow, market, or foreign currency risks. The Company evaluated the Public Warrants and private placement warrants
(the “Private Placement Warrants”, and collectively, “Warrants,” which are discussed in Note 3, Note 4, and Note
8) in accordance with Accounting Standards Codification (“ASC”) 815-40, “Derivatives and Hedging — Contracts in
Entity’s Own Equity”, and concluded that a provision in the Warrant Agreement related to certain tender or exchange offers
precludes the Warrants from being accounted for as components of equity. As the Warrants meet the definition of a derivative as contemplated
in ASC 815, the Warrants are recorded as derivative liabilities on the condensed balance sheets and measured at fair value at inception
(on the date of the IPO) and at each reporting date in accordance with ASC 820, “Fair Value Measurement”, with change in fair
value of warrant liabilities recognized in the unaudited condensed statements of operations in the period of change.
Offering Costs Associated with the Initial
Public Offering
The Company complies with the requirements of
the ASC 340-10-S99-1. Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the IPO that
were directly related to the IPO. Offering costs are allocated to the separable financial instruments issued in the IPO based on a relative
fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented
as other expenses in the condensed statements of operations. Offering costs associated with the Class A common stock were charged to temporary
equity upon the completion of the IPO. Transaction costs of the IPO amounted to an aggregate of $16,792,661, of which $457,600 was
allocated to expense associated with the warrant liability and $16,335,061 was charged to temporary equity.
Class A Common Stock Subject to Possible Redemption
All of the Public Shares sold as part of
the Units in the IPO contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s
liquidation, if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain
amendments to the Company’s second amended and restated certificate of incorporation. In accordance with SEC and its staff’s
guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control
of the Company require common stock subject to redemption to be classified outside of permanent equity. Ordinary liquidation events, which
involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. Accordingly,
at September 30, 2023 and December 31, 2022, all shares of Class A common stock subject to possible redemption are presented as temporary
equity, outside of the stockholders’ deficit section of the Company’s condensed balance sheets. The Company recognizes any
subsequent changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Class A common stock to
the redemption value at the end of each reporting period. Immediately upon the closing of the IPO, the Company recognized the accretion
from initial book value to redemption amount value of redeemable Class A common stock. This method would view the end of the reporting
period as if it were also the redemption date for the security. The change in the carrying value of redeemable Class A common stock also
resulted in charges against additional paid-in capital and accumulated deficit.
The Class A common stock subject to possible redemption
reflected on the condensed balance sheets as of September 30, 2023 and December 31, 2022 is reconciled in the following table:
Gross Proceeds | |
$ | 300,000,000 | |
Less: | |
| | |
Proceeds allocated to public warrants | |
| (8,175,000 | ) |
Class A common stock issuance costs | |
| (16,335,060 | ) |
Plus: | |
| | |
Accretion of carrying value to redemption value | |
| 24,510,060 | |
Class A common stock subject to possible redemption December 31, 2021 | |
| 300,000,000 | |
Plus: | |
| | |
Accretion of Class A common stock subject to possible redemption | |
| 3,211,829 | |
Class A common stock subject to possible redemption December 31, 2022 | |
| 303,211,829 | |
Less: | |
| | |
Redemption of Class A common stock | |
| (294,499,629 | ) |
Plus: | |
| | |
Accretion of Class A common stock subject to possible redemption | |
| 1,944,167 | |
Class A common stock subject to possible redemption September 30, 2023 | |
$ | 10,656,367 | |
Income Taxes
The Company accounts for income taxes under ASC
740, “Income Taxes.” ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact
of differences between the unaudited condensed financial statements and tax basis of assets and liabilities and for the expected future
tax benefit to be derived from tax loss and tax credit carryforwards. ASC 740 additionally requires a valuation allowance to be established
when it is more likely than not that all or a portion of deferred tax assets will not be realized. As of September 30, 2023 and December
31, 2022, the Company’s deferred tax asset had a full valuation allowance recorded against it.
ASC 740-270-25-2 requires that an annual effective
tax rate be determined and such annual effective rate applied to year to date income in interim periods under ASC 740-270-30-5. The Company’s
effective tax rate was 95.5% and 12.7% for the three months ended September 30, 2023 and 2022, respectively, 30.7% and 5.2% for the nine
months ended September 30, 2023 and 2022, respectively. The effective tax rate differs from the statutory tax rate of 21% for the three
and nine months ended September 30, 2023 and 2022, due to the change in fair value in warrant liability and the valuation allowance on
the deferred tax assets.
ASC 740 also clarifies the accounting for uncertainty
in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process
for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits
to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also provides
guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.
The Company recognizes accrued interest and penalties
related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest
and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could
result in significant payments, accruals or material deviation from its position.
The Company has identified the United States as
its only “major” tax jurisdiction. The Company has been subject to income taxation by major taxing authorities since inception.
These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and
compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits
will materially change over the next twelve months.
Net Income per Share of Common Stock
The Company complies with
accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. The Company has two classes of
shares, which are referred to as redeemable Class A common stock and non-redeemable Class A and Class B common stock. Income and
losses are shared pro rata between the two classes of shares. Net income per share is computed by dividing net income by the
weighted average number of shares outstanding during the period, excluding shares subject to forfeiture. The Company has not
considered the effect of the Warrants sold in the IPO and the Private Placement to purchase an aggregate
of 7,700,000 shares of the Company’s Class A common stock in the calculation of diluted income per share, since the
exercise of the Warrants are contingent upon the occurrence of future events. As a result, diluted net income per share is the same
as basic net income per share for the periods presented.
Accordingly, basic and diluted income per share
for Class A common stock and for Class B common stock is calculated as follows:
| |
For the Three Months Ended September 30, | | |
For the Nine Months Ended September 30, | |
| |
2023 | | |
2022 | | |
2023 | | |
2022 | |
| |
Redeemable Class A Common Stock | | |
Non-Redeemable
Class A and Class B Common Stock | | |
Redeemable Class A Common Stock | | |
Non-Redeemable
Class A and Class B Common Stock | | |
Redeemable Class A Common Stock | | |
Non-Redeemable
Class A and Class B Common Stock | | |
Redeemable Class A Common Stock | | |
Non-Redeemable
Class A and Class B Common Stock | |
Basic and diluted net income per share: | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
Numerator: | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
Allocation of net income | |
$ | 1,052 | | |
$ | 2,650 | | |
$ | 1,483,945 | | |
$ | 361,350 | | |
$ | 715,713 | | |
$ | 654,456 | | |
$ | 4,293,137 | | |
$ | 1,045,407 | |
Denominator: | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Weighted-average shares outstanding | |
| 3,296,904 | | |
| 8,300,000 | | |
| 30,000,000 | | |
| 8,300,000 | | |
| 9,076,870 | | |
| 8,300,000 | | |
| 30,000,000 | | |
| 8,300,000 | |
Basic and diluted net income per share | |
$ | 0.00 | | |
$ | 0.00 | | |
$ | 0.05 | | |
$ | 0.05 | | |
$ | 0.08 | | |
$ | 0.08 | | |
$ | 0.14 | | |
$ | 0.14 | |
Fair Value of Financial Instruments
The fair value of the Company’s assets and
liabilities, except for warrant liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements
and Disclosures,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their
short-term nature.
Recent Accounting Pronouncements
In August 2020, the FASB issued ASU No. 2020-06,
“Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s
Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU
2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP.
ASU 2020-06 removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception,
and it also simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective for fiscal years beginning
after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The Company is currently
assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows.
Management does not believe that any recently
issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed
financial statements.
Note 3 — Initial Public Offering
Public Units
On February 22, 2021, the Company sold 30,000,000 Units,
at a purchase price of $10.00 per Unit, which included the partial exercise by the underwriters of the over-allotment option resulting
in the purchase of an additional 3,500,000 Units. Each Unit consists of one share of Class A common stock, and one-fourth of
one redeemable Warrant to purchase one share of Class A common stock (the “Public Warrants”).
Public Warrants
As of September 30, 2023 and
December 31, 2022, the Company has 7,500,000 Public Warrants outstanding. Each whole Public Warrant entitles the holder to
purchase one share of the Company’s Class A common stock at a price of $11.50 per share, subject to adjustment as discussed
herein. Each Public Warrant will become exercisable on the later of 30 days after the completion of the initial Business Combination
or February 22, 2022, twelve (12) months from the date of the closing of the IPO, and will expire five years after the completion of
the initial Business Combination, or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional
shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the
initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with
such issue price or effective issue price to be determined in good faith by the Board and, in the case of any such issuance to the Company’s
Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or its affiliates, prior to such issuance)
(the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total
equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation
of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s
common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the initial
Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Warrants will be
adjusted (to the nearest cent) to be equal to 115% of the greater of the Market Value and the Newly Issued Price, the $18.00 per share
redemption trigger price described below under the caption “Redemption of warrants when the price per share of Class A common
stock equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and
the Newly Issued Price, and the $10.00 per share redemption trigger price described below under the caption “Redemption of warrants
when the price per share of Class A common Stock equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal
to the higher of the Market Value and the Newly Issued Price.
The Company will not be obligated to deliver any
shares of Class A common stock pursuant to the exercise of a Warrant and will have no obligation to settle such Warrant exercise
unless a registration statement under the Securities Act with respect to the shares of Class A common stock underlying the Warrants
is then effective and a current prospectus relating thereto is current. No Warrant will be exercisable and the Company will not be obligated
to issue shares of Class A common stock upon exercise of a Warrant unless Class A common stock issuable upon such Warrant exercise
has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of
the Warrants. In no event will the Company be required to net cash settle any Warrant. In the event that a registration statement is not
effective for the exercised Warrants, the purchaser of a unit containing such Warrant will have paid the full purchase price for the unit
solely for the share of Class A common stock underlying such unit.
Redemption of Warrants When the Price per Share
of Class A Common Stock Equals or Exceeds $18.00
Once the Warrants become exercisable, the Company
may redeem the outstanding Warrants:
| ● | in
whole and not in part; |
| ● | at
a price of $0.01 per Warrant; |
| ● | upon
not less than 30 days’ prior written notice of redemption given after the Warrants become exercisable (the “30-day redemption
period”) to each Warrant holder; and |
| ● | if,
and only if, the reported last sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock
splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period
ending three business days before the Company sends the notice of redemption to the Warrant holders. |
Redemption of Warrants When the Price per Share
of Class A Common Stock Equals or Exceeds $10.00
Once the Warrants become exercisable, the Company
may redeem the outstanding Warrants:
| ● | in
whole and not in part; |
| ● | at
a price of $0.10 per Warrant, upon a minimum of 30 days’ prior written notice of redemption, provided that holders
will be able to exercise their Warrants, but only on a cashless basis, prior to redemption based on the redemption date and the “fair
market value” of Class A common stock except as otherwise described below; |
| ● | if,
and only if, the reported last sale price of the Class A common stock equals or exceeds $10.00 per share (as adjusted for stock
splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days (the “Reference Days”)
within a 30-trading day period ending three business days before the Company sends the notice of redemption to the Warrant holders;
and |
| ● | if
the reported last sale price of the Class A common stock is less than $18.00 per share (as adjusted for stock splits, stock dividends,
reorganizations, recapitalizations and the like) for the Reference Days, the Private Placement Warrants are also concurrently called
for redemption on the same terms as the outstanding Public Warrants, as described above. |
If the Company calls the Warrants for redemption
as described above, the management will have the option to require all holders that wish to exercise Warrants to do so on a cashless basis.
In determining whether to require all holders to exercise their Warrants on a cashless basis, the management will consider, among other
factors, the Company’s cash position, the number of Warrants that are outstanding and the dilutive effect on its stockholders of
issuing the maximum number of shares of Class A common stock issuable upon the exercise of the Warrants. In such event, each holder
would pay the exercise price by surrendering the Warrants for that number of shares of Class A common stock equal to the lesser of
(A) the quotient obtained by dividing (x) the product of the number of shares of Class A common stock underlying the Warrants
multiplied by the excess of the “fair market value” (defined below) over the exercise price of the Warrant by (y) the
fair market value and (B) 0.361 per whole Warrant. The “fair market value” shall mean the average reported closing
price of the Class A common stock for the ten trading days ending on the third trading day prior to the date on which the notice
of redemption is sent to the holders of Warrants.
Note 4 — Private Placement
Simultaneously with the closing of the IPO, the
Sponsor purchased an aggregate of 800,000 Placement Units at a price of $10.00 per Placement Unit, for an aggregate purchase
price of $8,000,000, in the Private Placement. A portion of the proceeds from the Private Placement was added to the proceeds from the
IPO held in the Trust Account.
Each Placement Unit is identical to the Units
offered in the IPO except as described below. There will be no redemption rights or liquidating distributions from the Trust Account with
respect to the Founder Shares, placement shares or Private Placement Warrants, which will expire worthless if the Company does not consummate
a Business Combination within the Combination Period.
As of September 30, 2023 and December 31, 2022,
the Company has 200,000 Private Placement Warrants outstanding. The Private Placement Warrants will be identical to Public Warrants
except that the Private Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) will not be
redeemable by the Company, (ii) may not, subject to certain limited exceptions, be transferred, assigned or sold by the holders until
30 days after the completion of the Company’s initial Business Combination, (iii) may be exercised by the holders on a cashless
basis.
The Company’s initial stockholders have
agreed to waive their redemption rights with respect to their placement shares (i) in connection with the consummation of a Business
Combination, (ii) in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation
to modify the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination
or certain amendments to the Company’s charter prior thereto, to redeem 100% of the Public Shares if the Company does not complete
the initial Business Combination within the Combination Period or with respect to any other provision relating to stockholders’
rights or pre-initial Business Combination activity and (iii) if the Company fails to consummate a Business Combination within
the Combination Period or if the Company liquidates prior to the expiration of the Combination Period. However, the initial stockholders
will be entitled to redemption rights with respect to any Public Shares held by them if the Company fails to consummate a Business Combination
or liquidate within the Combination Period.
Note 5 — Related Party Transactions
Founder Shares
In December 2020, the Company’s initial
stockholders paid $25,000, or approximately $0.003 per share, in consideration for an aggregate of 7,187,500 shares of
Class B common stock par value $0.0001. In February 2021, the Company effected a stock dividend of 0.06 shares for each share
of Class B common stock outstanding, resulting in the Sponsor holding an aggregate number of 7,618,750 shares of Class B common
stock, including an aggregate of up to 993,750 shares subject to forfeiture if the over-allotment option was not exercised by
the underwriters in full. On February 22, 2021, as a result of the underwriters’ election to partially exercise their over-allotment
option, a proportionate number of Founder Shares, aggregating 118,750, were forfeited, resulting in the Sponsor holding an aggregate
of 7,500,000 shares of Class B common stock.
With certain limited exceptions, the Founder
Shares are not transferable, assignable or salable (except to the Company’s officers and directors and other persons or entities
affiliated with the Sponsor, each of whom will be subject to the same transfer restrictions) until the earlier of (A) six months
after the completion of the Company’s initial Business Combination or (B) subsequent to the Company’s initial Business
Combination, (x) if the last sale price of the Company’s Class A common stock equals or exceeds $12.00 per share (as adjusted
for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day
period commencing at least 90 days after the initial Business Combination, or (y) the date, following the completion of the
Company’s initial Business Combination, on which the Company completes a liquidation, merger, capital stock exchange, reorganization
or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common
stock for cash, securities or other property.
On January 30, 2023, the holders of 7,499,999
shares of Class B common stock exercised their right to convert these shares into equivalent number of shares of Class A ordinary shares
(the “Conversion”).
The 7,499,999 Class A ordinary shares issued in
connection with the conversion are subject to the same restrictions as applied to the Class B ordinary shares before the Conversion, including,
among other things, (i) certain transfer restrictions, (ii) waiver of redemption rights, (iii) waiver of rights to receive liquidating
distributions from the Company’s trust account and (iv) the obligation to vote in favor of an initial Business Combination as described
in the prospectus for the Company’s Initial Public Offering. In addition, following the Conversion, certain additional restrictions
pursuant to Regulation S of the Securities Act apply to the Class A ordinary shares of the Holders.
Promissory Note — Related Party
On December 23, 2020, the Company issued an unsecured
promissory note to the Sponsor for an aggregate of up to $300,000 to cover expenses related to the IPO. This loan was non-interest bearing
and payable on the earlier of December 31, 2021 or the completion of the IPO. On February 22, 2021, the Company paid the balance of the
promissory note in full from the IPO proceeds, and it is no longer available to be drawn upon.
On August 22, 2023, the Company issued a promissory
note (the “Working Capital Note”) in the aggregate principal amount of up to $400,000 to the Company’s sponsor, FinServ
Holdings II, LLC (the “Sponsor”) pursuant to which the Sponsor agreed to loan to the Company up to $400,000 for working capital
expenses. The Working Capital Note bears no interest and is repayable in full upon the earlier of (a) the date of the consummation of
an initial business combination (the “Business Combination”) and (b) the date of the Company’s liquidation. As of September
30, 2023 $125,000 was drawn and outstanding under the Working Capital Note.
Related Party Loans
In order to finance transaction costs in connection
with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may,
but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a
Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company.
Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination
does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans
but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital
Loans may be convertible into units at a price of $10.00 per unit at the option of the lender. The Units would be identical to the
Placement Units. As of September 30, 2023 and December 31, 2022, no such Working Capital Loans were outstanding.
Administrative Services Agreement
The Company entered into an agreement whereby,
commencing on April 1, 2021 through the earlier of the consummation of the Initial Business Combination or the Company’s liquidation,
the Company agreed to pay, if requested by the Sponsor, a monthly fee of up to $10,000 for office space, utilities and administrative
support. Upon completion of the Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees.
No fees were requested, paid or accrued for the three and nine months ended September 30, 2023 and 2022.
Consulting Agreement
On August 12, 2022, the Company
entered into an agreement with a consulting company (the “Advisor”) to perform such services as requested by the Company
from time to time. The principal of the Advisor is the chief financial officer of the Company. The term of this Agreement shall commence
on August 12, 2022 and terminate upon the earlier of (a) termination of this engagement at will in accordance with the terms of this
Agreement; or (b) the consummation of a Business Combination. As full compensation for the services on behalf of the Company, or any
of its officers, directors, shareholders, or employees, the Company shall pay a quarterly fee of $30,000. During the three and nine months
ended September 30, 2023, the Company paid and recorded $90,000 such fees. During the three and nine months ended September 30, 2022,
the Company paid and recorded $30,000 such fees.
Note 6 — Commitments
and Contingencies
Registration Rights
The holders of the Founder Shares, Placement Units
(including the underlying securities), and Units that may be issued upon conversion of Working Capital Loans (including the underlying
securities) and Class A common stock issuable upon conversion of the Founder Shares, are entitled to registration rights pursuant
to a registration rights agreement to be signed prior to or on the effective date of the IPO, requiring the Company to register such securities
for resale. The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that
the Company registers such securities. In addition, the holders have certain “piggyback” registration rights with respect
to registration statements filed subsequent to the completion of the initial Business Combination and rights to require the Company to
register for resale such securities pursuant to Rule 415 under the Securities Act.
Underwriting Agreement
The underwriter had a 45-day option from the date
of the IPO to purchase up to an aggregate of 3,975,000 additional Units at the public offering price less the underwriting commissions
to cover over-allotments, if any. On February 22, 2021, the underwriter partially exercised their over-allotment option and purchased 3,500,000 additional
Units and were paid a cash underwriting discount of $0.20 per Unit, or $6,000,000 in the aggregate.
The underwriters are entitled to deferred underwriting
fee of 3.5% of the gross proceeds of the IPO, or $10,500,000 in the aggregate. The deferred fee will be payable to the underwriters
from the amounts held in the Trust Account solely in the event that the Company completes an initial Business Combination, subject to
the terms of the underwriting agreement.
Non-Redemption Agreements
In February 2023, the Sponsor entered into non-redemption
agreements (“Non-Redemption Agreements”) with unaffiliated parties in exchange for such parties’ agreement not to redeem
an aggregate of 4,850,000 shares of the Company sold in its initial public offering (“Non-Redeemed Shares”) in connection
with the First Extension Meeting to consider and approve an extension of time for the Company to consummate an initial Business Combination
from February 22, 2023 to August 22, 2023, or such earlier date as determined by the Board. In exchange for the foregoing commitments
not to redeem such Non-Redeemed Shares, the Sponsor has agreed to transfer to such parties an aggregate of 1,000,000 shares of the Company
held by the Sponsor immediately following consummation of an initial Business Combination if they continued to hold such Non-Redeemed
Shares through the First Extension Meeting. The Non-Redeemed shares retain the right to redeem their shares at any future applicable redemption
event under the Non-Redemption Agreements. In addition, the Company has agreed that, to mitigate the current uncertainty surrounding the
implementation of the Inflation Reduction Act of 2022, funds held in the Trust Account, including any interest thereon, will not be used
to pay for any excise tax liabilities with respect to any future redemptions prior to or in connection with the First Extension, an initial
business combination, or liquidation of the Company.
Special Meeting
On February 20, 2023, the Company held the First
Extension Meeting. At the First Extension Meeting, the Company’s stockholders approved the First Extension Amendment to extend the
date by which the Company must consummate its initial Business Combination from February 22, 2023 to August 22, 2023, or such earlier
date as determined by the Company’s Board. In connection with the First Extension Meeting, stockholders holding 25,040,997 shares
of the Company’s Class A common stock issued in the Company’s IPO exercised their right to redeem such shares for a pro rata
portion of the funds in the Company’s Trust Account. As a result, approximately $254,201,240 (approximately $10.15 per share) was
removed from the Company’s Trust Account to pay such stockholders.
On August 18, 2023, the Company held the Second
Extension Meeting. At the Second Extension Meeting, the Company’s stockholders approved (1) the Second Extension Amendment to extend
the date by which the Company must consummate its Business Combination from August 22, 2023 to February 22, 2024 (or such earlier date
as determined by the Board); and (2) the Redemption Limitation Amendment to eliminate from the Charter the limitation that the Company
will only redeem the Public Shares so long as (after such redemption), the Company’s net tangible assets, or of any entity that
succeeds to the Company as a public company, will be at least $5,000,001 either immediately prior to or upon consummation of the Business
Combination. The Company filed the Second Extension Amendment with the Secretary of State of the State of Delaware on August 18, 2023.
The Company filed the Redemption Limitation Amendment with the Secretary of State of the State of Delaware on August 23, 2023.
In connection with the Second Extension Meeting,
stockholders holding 3,920,848 Public Shares exercised their right to redeem their shares for a pro rata portion of the funds in the Trust
Account. As a result, approximately $40,298,391 (approximately $10.28 per Public Share) was removed from the Trust Account to pay such
holders and approximately $10,670,135 will remain in the Trust Account. Following redemptions, the Company has 9,338,154 shares of Class
A common stock outstanding.
Note 7 — Stockholders’ Deficit
Preferred Stock — The
Company is authorized to issue a total of 1,000,000 shares of preferred stock at par value of $0.0001 per share. At
September 30, 2023 and December 31, 2022, there were no shares of preferred stock issued or outstanding.
Class A Common Stock —
The Company is authorized to issue a total of 100,000,000 shares of Class A common stock at par value of $0.0001 per
share. On January 30, 2023 7,499,999 shares of Class B common stock were converted to Class A common stock. On February 20, 2023, in connection
with the Extension, stockholders holding 25,040,997 shares of the Company’s Class A common stock exercised their right to redeem
such shares. At September 30, 2023 and December 31, 2022, there were 8,299,999 and 800,000 shares issued and outstanding, excluding 1,038,155
shares and 30,000,000 shares subject to possible redemption, respectively.
Class B Common Stock —
The Company is authorized to issue a total of 10,000,000 shares of Class B common stock at par value of $0.0001 per
share. At September 30, 2023 and December 31, 2022, there was one and 7,500,000 shares issued and outstanding, respectively.
The Company’s Sponsor, directors and officers
have agreed not to transfer, assign or sell their Founder Shares until the earlier to occur of (A) six months after the completion
of the Company’s initial Business Combination or (B) subsequent to the Company’s initial Business Combination, (x) if
the last sale price of the Company’s Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits,
stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing
at least 90 days after the initial Business Combination, or (y) the date, following the completion of the Company’s initial
Business Combination, on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction
that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities
or other property.
The shares of Class B common stock will automatically
convert into shares of Class A common stock at the time of the initial Business Combination on a one-for-one basis (subject
to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like), and subject to further adjustment as
provided herein. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed
issued in excess of the amounts offered in IPO and related to the closing of the initial Business Combination, the ratio at which shares
of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority
of the outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance)
so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal,
in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon
completion of the IPO (excluding the Placement Units and underlying securities) plus all shares of Class A common stock and equity-linked securities
issued or deemed issued in connection with the initial Business Combination (excluding any shares or equity-linked securities issued,
or to be issued, to any seller in the initial Business Combination, any private-equivalent units and their underlying securities
issued to the Sponsor or its affiliates upon conversion of loans made to the Company).
Holders of record of the Class A common stock
and holders of record of the Class B common stock will vote together as a single class on all matters submitted to a vote of the Company’s
stockholders, with each share of common stock entitling the holder to one vote except as required by law.
Note 8 — Fair Value Measurements
The Company follows the guidance in ASC 820, “Fair
Value Measurement,” for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period,
and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.
The fair value of the Company’s financial
assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale
of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the
measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of
observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions
about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities
based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
|
Level 1 — |
Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment. |
|
Level 2 — |
Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means. |
|
Level 3 — |
Valuations based on inputs that are unobservable and significant to the overall fair value measurement. |
The following table presents information about
the Company’s assets and liabilities that are measured at fair value on a recurring basis at September 30, 2023 and December 31,
2022, and indicate the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
| |
September 30, | | |
Quoted Prices In Active Markets | | |
Significant Other Observable Inputs | | |
Significant Other Unobservable Inputs | |
| |
2023 | | |
(Level 1) | | |
(Level 2) | | |
(Level 3) | |
Assets: | |
| | |
| | |
| | |
| |
Demand deposit account | |
$ | 10,722,779 | | |
$ | 10,722,779 | | |
$ | — | | |
$ | — | |
Investments in mutual funds | |
| 47,663 | | |
| 47,663 | | |
| — | | |
| — | |
| |
$ | 10,770,442 | | |
$ | 10,770,442 | | |
$ | — | | |
$ | — | |
Liabilities: | |
| | | |
| | | |
| | | |
| | |
Public Warrants Liability | |
$ | 226,500 | | |
$ | — | | |
$ | 226,500 | | |
$ | — | |
Private Placement Warrants Liability | |
| 6,040 | | |
| — | | |
| 6,040 | | |
| — | |
| |
$ | 232,540 | | |
$ | — | | |
$ | 232,540 | | |
$ | — | |
| |
December 31, | | |
Quoted Prices In Active Markets | | |
Significant Other Observable Inputs | | |
Significant Other Unobservable Inputs | |
| |
2022 | | |
(Level 1) | | |
(Level 2) | | |
(Level 3) | |
Assets: | |
| | |
| | |
| | |
| |
U.S. Money Market held in Trust Account | |
$ | 303,511,593 | | |
$ | 303,511,593 | | |
$ | — | | |
$ | — | |
Investments in mutual funds | |
| 549,408 | | |
| 549,408 | | |
| — | | |
| — | |
| |
$ | 304,061,001 | | |
$ | 304,061,001 | | |
$ | — | | |
$ | — | |
Liabilities: | |
| | | |
| | | |
| | | |
| | |
Public Warrants Liability | |
$ | 75,000 | | |
$ | 75,000 | | |
$ | — | | |
$ | — | |
Private Placement Warrants Liability | |
| 2,000 | | |
| — | | |
| 2,000 | | |
| — | |
| |
$ | 77,000 | | |
$ | 75,000 | | |
$ | 2,000 | | |
$ | — | |
Level 1 assets include investments in mutual funds
and money market funds invested in government securities. The Company uses inputs such as actual trade data, benchmark yields, quoted
market prices from dealers or brokers, and other similar sources to determine the fair value of its investments.
The Warrants are accounted for as liabilities
in accordance with ASC 815-40 and are presented within warrant liabilities on the unaudited condensed balance sheets. The warrant liabilities
are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of
warrant liability in the unaudited condensed statements of operations.
The Company established the initial fair value
of the Public and Private Warrants on February 22, 2021, the date of the Company’s IPO, using a Monte Carlo simulation model and
modified Black-Sholes model. The Warrants were classified as Level 3 at the initial measurement date due to the use of unobservable inputs.
As of December 31, 2021, the Company used the quoted market price as the fair value of the Public Warrants and the Public Warrants were
reclassified from Level 3 to Level 1. Due to certain “make whole” provisions in the Warrant agreement, the Company also used
the quoted market price of the Public Warrants as the fair value of the Private Warrants as of December 31, 2021 and reclassified the
Private Warrants from Level 3 to Level 2, due to the use of the quoted price of a similar liability. For the three and nine months ended
September 30, 2023, the Company transferred the Public Warrants from Level 1 to Level 2 due to low trading volume.
Note 9 — Subsequent
Events
The Company evaluated subsequent events and transactions
that occurred after the condensed balance sheet date up to the date that the unaudited condensed financial statements were issued. Based
upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited
condensed financial statements.
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Cautionary Note Regarding Forward-Looking Statements
All statements other
than statements of historical fact included in this Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 (“Report”)
including, without limitation, statements in this section regarding our financial position, business strategy and the plans and objectives
of management for future operations, are forward-looking statements. When used in this Report, words such as “anticipate,”
“believe,” “estimate,” “expect,” “intend” and similar expressions, as they relate to us
or our management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of our management, as
well as assumptions made by, and information currently available to, our management. Actual results could differ materially from those
contemplated by the forward-looking statements as a result of certain factors detailed in our filings with the SEC. All subsequent written
or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph.
The following discussion
and analysis of our financial condition and results of operations should be read in conjunction with the unaudited
condensed financial statements and the notes thereto included in this Report under “Item 1. Financial Statements”.
Overview
We are a blank check company incorporated in Delaware
on November 23, 2020 for the purpose of effecting a Business Combination with one or more businesses. Our Sponsor is FinServ Holdings
II LLC, a Delaware limited liability company.
Our IPO Registration Statement was declared effective
on February 17, 2021. On February 22, 2021, we consummated the IPO of 30,000,000 Units, at $10.00 per Unit, generating gross proceeds
of $300.0 million, and incurring offering costs of approximately $16.8 million, inclusive of $10.5 million in deferred underwriting commissions.
Simultaneously with the closing of the IPO, we
consummated the Private Placement of 800,000 Units at a price of $10.00 per Unit to the Sponsor, generating gross proceeds of approximately
$8.0 million.
Upon the closing of the IPO and the Private Placement
on February 22, 2021, $300.0 million ($10.00 per Unit) of the net proceeds of the sale of the Units in the IPO and the Private Placement
were placed in a Trust Account located in the United States with Continental Stock Transfer & Trust Company (“Continental”)
acting as trustee, and invested only in U.S. “government securities,” within the meaning of Section 2(a)(16) of the Investment
Company Act of 1940, as amended (the “Investment Company Act”), having a maturity of 185 days or less or in money market funds
meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act, which invest only in direct U.S. government treasury
obligations, as determined by us, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the
Trust Account as described below.
On February 20, 2023, the Company held the First
Extension Meeting. At the First Extension Meeting, the Company’s stockholders approved the First Extension Amendment to extend the
date by which the Company must consummate its initial Business Combination from February 22, 2023 to August 22, 2023, or such earlier
date as determined by the Company’s Board. In connection with the First Extension Meeting, stockholders holding 25,040,997 shares
of the Company’s Class A common stock issued in the Company’s IPO exercised their right to redeem such shares for a pro rata
portion of the funds in the Company’s Trust Account. As a result, approximately $254,201,240 (approximately $10.15 per share) was
removed from the Company’s Trust Account to pay such stockholders.
On August 18, 2023, the Company held the Second
Extension Meeting. At the Second Extension Meeting, the Company’s stockholders approved (1) the Second Extension Amendment to extend
the date by which the Company must consummate its Business Combination from August 22, 2023 to February 22, 2024 (or such earlier date
as determined by the Board); and (2) the Redemption Limitation Amendment to eliminate from the Charter the limitation that the Company
will only redeem the Public Shares so long as (after such redemption), the Company’s net tangible assets, or of any entity that
succeeds to the Company as a public company, will be at least $5,000,001 either immediately prior to or upon consummation of the Business
Combination. The Company filed the Second Extension Amendment with the Secretary of State of the State of Delaware on August 18, 2023.
The Company filed the Redemption Limitation Amendment with the Secretary of State of the State of Delaware on August 23, 2023.
In connection with the Second Extension Meeting,
stockholders holding 3,920,848 Public Shares exercised their right to redeem their shares for a pro rata portion of the funds in the Trust
Account. As a result, approximately $40,298,391 (approximately $10.28 per Public Share) was removed from the Trust Account to pay such
holders and approximately $10,670,135 will remain in the Trust Account. Following redemptions, the Company has 9,338,154 shares of Class
A common stock outstanding.
If we have not completed an initial Business Combination
during the Combination Period, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably
possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in
cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account
and not previously released to us to pay its taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number
of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including
the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption,
subject to the approval of the remaining stockholders and our board of directors, liquidate and dissolve, subject in each case to our
obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.
Results of Operations
For the three months ended September 30, 2023,
we had a net income of $3,702, which included income on investments in mutual funds of $1,105 and interest earned on cash and marketable
securities held in the Trust Account of $327,077, offset by a loss from operations of $202,530, a loss from the change in fair value of
warrant liabilities of $43,120 and provision for income taxes of $78,830.
For the nine months ended September 30, 2023,
we had a net income of $1,370,169, which included income on investments in mutual funds of $15,444 and interest earned on cash and marketable
securities held in the Trust Account of $2,911,687, offset by a loss from the change in fair value of warrant liabilities of $155,540,
a loss from operations of $795,060 and provision for income taxes of $606,362.
For the three months ended September 30, 2022,
we had a net income of $1,845,295, which included income on investments in mutual funds of $289, a gain from the change in fair value
of warrant liabilities of $1,001,000 and interest earned on cash and marketable securities held in the Trust Account of $1,323,260, offset
by a loss from operations of $211,809 and provision for income taxes of $267,445.
For the nine months ended September 30, 2022,
we had a net income of $5,338,544, which included a gain from the change in fair value of warrant liabilities of $4,543,000 and interest
earned on cash and marketable securities held in the Trust Account of $1,731,082, offset by a loss on investments in mutual funds of $31,939,
a loss from operations of $612,419, and provision for income taxes of $291,180.
Our business activities from inception to September
30, 2023 consisted primarily of our formation and completing our IPO, and since the offering, our activity has been limited to identifying
and evaluating prospective acquisition targets for a Business Combination.
Factors That May Adversely Affect Our Results
of Operations
Our results of operations and our ability to complete
an initial Business Combination may be adversely affected by various factors that could cause economic uncertainty and volatility in the
financial markets, many of which are beyond our control. Our business could be impacted by, among other things, downturns in the financial
markets or in economic conditions, increases in oil prices, inflation, increases in interest rates, supply chain disruptions, declines
in consumer confidence and spending, the ongoing effects of the COVID-19 pandemic, including resurgences and the emergence of new variants,
and geopolitical instability, such as the military conflict in Ukraine and the Middle East. We cannot at this time fully predict the likelihood
of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact our business and our
ability to complete an initial Business Combination.
Liquidity and Capital Resources
As of September 30, 2023, we had $84,617 in our
operating bank account and $47,663 in money market account and working capital deficit of $2,871,663.
In connection with the Company’s assessment
of going concern considerations in accordance with Financial Accounting Standard Board (“FASB”) Accounting Standards Update
(“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,”
the Company has until February 22, 2024, to consummate a Business Combination. It is uncertain whether the Company will be able to consummate
a Business Combination by this time. The Company also has incurred and expects to continue to incur significant costs in pursuit of its
financing and acquisition plans. If the Company’s estimates of the costs of identifying a target business, undertaking in-depth
due diligence, and negotiating a Business Combination are less than the actual amount necessary to do so, the Company may have insufficient
funds to operate its business prior to the date of business combination. If a Business Combination is not consummated by February 22,
2024, and if there are no further amendments to extend the date of the Business Combination beyond February 22, 2023, there will be a
mandatory liquidation and subsequent dissolution of the Company. Management will continue to search for a Business Combination, however,
there is no assurance the Company will find a suitable target. Management has determined that potential liquidity shortfall and mandatory
liquidation deadline raise substantial doubt about the Company’s ability to continue as a going concern.
On February 21, 2023, we instructed Continental
to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in an interest-bearing
demand deposit account at a bank, with Continental continuing to act as trustee, until the earlier of the consummation of our initial
Business Combination or our liquidation. As a result, following the liquidation of investments in the Trust Account, the remaining
proceeds from the IPO and the Private Placement are no longer invested in U.S. government securities or money market funds.
Administrative Services Agreement
We entered into an agreement whereby, commencing
on April 1, 2021 through the earlier of the consummation of an initial Business Combination or our liquidation, we agreed to pay the Sponsor
a monthly fee of up to $10,000 for office space, utilities and administrative support. Upon completion of an initial Business Combination
or our liquidation, we will cease paying these monthly fees. For nine months ended September 30, 2023, we did not incur fees for these
services.
Consulting Agreement
On August 12, 2022, we entered into an agreement
with the Advisor to perform such services as requested by us from time to time. The principal of the Advisor is our Chief Financial Officer.
The term of the agreement commenced on August 12, 2022 and will terminate upon the earlier of (a) termination of this engagement at will
in accordance with the terms of the agreement; or (b) the consummation of a Business Combination. As full compensation for the services
on behalf of the Company, or any of its officers, directors, shareholders, or employees, we pay a quarterly fee of $30,000 to the Advisor.
During the three and nine months ended September 30, 2023, the Company paid and recorded $90,000 such fees. During the three and nine
months ended September 30, 2022, the Company paid and recorded $30,000 such fees.
Contractual Obligations
We do not have any long-term debt obligations,
capital lease obligations, operating lease obligations, purchase obligations or long-term liabilities.
Critical Accounting Estimates
This management’s discussion and analysis
of our financial condition and results of operations is based on our unaudited condensed financial statements, which have been prepared
in accordance with U.S. GAAP. The preparation of these unaudited condensed financial statements requires us to make estimates and judgments
that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities
in our unaudited condensed financial statements. On an ongoing basis, we evaluate our estimates and judgments, including those related
to fair value of financial instruments and accrued expenses. We base our estimates on historical experience, known trends and events and
various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments
about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these
estimates under different assumptions or conditions.
Except as set forth below, there have been no
significant changes in our critical accounting policies as discussed in the Annual Report on Form 10-K filed by us with the SEC on March
31, 2023.
Class A Common Stock Subject to Possible
Redemption
All of the Public Shares sold as part of the Units
in the IPO contain a redemption feature which allows for the redemption of such Public Shares in connection with our liquidation, if there
is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to our second
amended and restated certificate of incorporation. In accordance with SEC and its staff’s guidance on redeemable equity instruments,
which has been codified in ASC 480-10-S99, redemption provisions not solely within our control require common stock subject to redemption
to be classified outside of permanent equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the
entity’s equity instruments, are excluded from the provisions of ASC 480. Accordingly, at September 30, 2023 and December 31, 2022,
all shares of Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’
deficit section of our condensed balance sheets.
We recognize any subsequent changes in redemption
value immediately as they occur and adjust the carrying value of redeemable Class A common stock to the redemption value at the end of
each reporting period. Immediately upon the closing of the IPO, we recognized the accretion from initial book value to redemption amount
value of redeemable Class A common stock. This method would view the end of the reporting period as if it were also the redemption date
for the security. The change in the carrying value of redeemable Class A common stock also resulted in charges against Additional paid-in
capital and Accumulated deficit.
Warrants Liability
We evaluated the Warrants in accordance with ASC
815-40, “Derivatives and Hedging — Contracts in Entity’s Own Equity”, and concluded that a provision in the Warrant
Agreement related to certain tender or exchange offers as well as provisions that provided for potential changes to the settlement amounts
dependent upon the characteristics of the holder of the Warrant, precludes the Warrants from being accounted for as components of equity.
As the Warrants meet the definition of a derivative as contemplated in ASC 815 and are not eligible for an exception from derivative accounting,
the Warrants are recorded as derivative liabilities on the condensed Balance Sheets and measured at fair value at inception (on the date
of the IPO) and at each reporting date in accordance with ASC 820, “Fair Value Measurement”, with changes in fair value recognized
in the condensed Statements of Operations in the period of change.
Net Income Per Share of Common Stock
We comply with accounting and disclosure requirements
of FASB ASC Topic 260, “Earnings Per Share.” We have two classes of shares, which are referred to as Class A common stock
and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income per share is computed by
dividing net income by the weighted average number of shares outstanding during the period, excluding shares subject to forfeiture. We
have not considered the effect of the Warrants sold in the IPO and the Private Placement to purchase an aggregate of 7,700,000 shares
of our Class A common stock in the calculation of diluted income per share, since the exercise of the Warrants are contingent upon the
occurrence of future events. As a result, diluted net income per share is the same as basic net income per share for the periods presented.
Recent Accounting Pronouncements
Our management does not believe that any recently
issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed
financial statements.
JOBS Act
On April 5, 2012, the JOBS Act was signed into
law. The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies.
We qualify as an “emerging growth company” under the JOBS Act and are allowed to comply with new or revised accounting pronouncements
based on the effective date for private (not publicly traded) companies. We elected to delay the adoption of new or revised accounting
standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such
standards is required for non-emerging growth companies. As a result, our financial statements may not be comparable to companies that
comply with new or revised accounting pronouncements as of public company effective dates.
As an “emerging growth company,” we
are not required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial
reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public
companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by
the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about
the audit and the financial statements (auditor discussion and analysis), and (iv) disclose certain executive compensation related items
such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee
compensation. These exemptions will apply for a period of five years following the completion of our IPO or until we are no longer an
“emerging growth company,” whichever is earlier.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES
ABOUT MARKET RISK
We are a smaller reporting company as defined
by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.
ITEM 4. CONTROLS AND PROCEDURES
Disclosure controls and procedures are controls
and other procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange
Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms. Disclosure
controls and procedures include, without limitation, controls and procedures designed to ensure that such information is accumulated and
communicated to our management, including our principal executive officer and principal financial officer or persons performing similar
functions, as appropriate to allow timely decisions regarding required disclosure.
Evaluation of Disclosure Controls and Procedures
Under the supervision and with the participation
of our management, including our principal executive officer and principal financial and accounting officer, we conducted an evaluation
of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended September 30, 2023, as such term
is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal
financial and accounting officer have concluded that during the period covered by this report, our disclosure controls and procedures
were effective. Accordingly, management believes that the financial statements included in this report present fairly in all material
respects our financial position, results of operations and cash flows for the period presented.
We do not expect that our disclosure controls
and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and
operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met.
Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits
must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation
of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances
of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of
future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.
Changes in Internal Control over Financial
Reporting
There was no change in our internal control over
financial reporting that occurred during the fiscal quarter of 2023 covered by this report on Form 10-Q that has materially affected,
or is reasonably likely to materially affect, our internal control over financial reporting.
PART II - OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS.
To the knowledge of our management team, there
is no litigation currently pending or contemplated against us, any of our officers or directors in their capacity as such or against any
of our property.
ITEM 1A. RISK FACTORS.
As a smaller reporting company under Rule 12b-2
of the Exchange Act, we are not required to include risk factors in this report. However, as of the date of this report, other than as
set forth below, there have been no material changes with respect to those risk factors previously disclosed in (i) our final prospectus
for our IPO, as filed with the SEC on February 17, 2021, (ii) our Annual Reports on Form 10-K for the fiscal years ended December 31,
2021 and December 31, 2022, as filed with the SEC on March 29, 2022 and March 31, 2023, respectively, (iii) our Quarterly Report on Form
10-Q for the period ended March 31, 2022, as filed with the SEC on May 13, 2022, (iv) our Quarterly Report on Form 10-Q for the period
ended June 30, 2022, as filed with the SEC on August 12, 2022, (v) our Quarterly Report on Form 10-Q for the period ended September 30,
2022, as filed with the SEC on November 14, 2022, and (vi) our definitive proxy statement, as filed with the SEC on August 2, 2023; and
(vii) our Quarterly Report on Form 10-Q for the period ended March 31, 2023, as filed with the SEC on May 15, 2023. Any of these factors
could result in a significant or material adverse effect on our results of operations or financial condition. Additional risks could arise
that may also affect our business or ability to consummate an initial Business Combination. We may disclose changes to such risk factors
or disclose additional risk factors from time to time in our future filings with the SEC.
Military or other conflicts in Ukraine,
the Middle East or elsewhere may lead to increased volume and price volatility for publicly traded securities, or affect the operations
or financial condition of potential target companies, which could make it more difficult for us to consummate an initial Business Combination.
Military or other conflicts in Ukraine, the Middle
East or elsewhere may lead to increased volume and price volatility for publicly traded securities, or affect the operations or financial
condition of potential target companies, and to other company or industry-specific, national, regional or international economic disruptions
and economic uncertainty, any of which could make it more difficult for us to identify a Business Combination target and consummate an
initial Business Combination on acceptable commercial terms, or at all.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES
AND USE OF PROCEEDS.
Unregistered Sales
of Equity Securities
None.
Use of Proceeds
For a description of the use of proceeds generated
in our IPO and Private Placement, see Part II, Item 2 of the Company’s Quarterly Report on Form 10-Q for the quarter ended March
31, 2021, as filed with the SEC on May 24, 2021. There has been no material change in the planned use of proceeds from the Company’s
IPO and Private Placement as described in the IPO Registration Statement.
Purchases of Equity Securities by the Issuer
and Affiliated Purchasers
On August 18, 2023, the Company held the Second
Extension Meeting. At the Second Extension Meeting, the Company’s stockholders approved (1) the Second Extension Amendment to extend
the date by which the Company must consummate its Business Combination from August 22, 2023 to February 22, 2024 (or such earlier date
as determined by the Board); and (2) the Redemption Limitation Amendment to eliminate from the Charter the limitation that the Company
will only redeem the Public Shares so long as (after such redemption), the Company’s net tangible assets, or of any entity that
succeeds to the Company as a public company, will be at least $5,000,001 either immediately prior to or upon consummation of the Business
Combination. The Company filed the Second Extension Amendment with the Secretary of State of the State of Delaware on August 18, 2023.
The Company filed the Redemption Limitation Amendment with the Secretary of State of the State of Delaware on August 23, 2023. In connection
with the Second Extension Meeting, stockholders holding 3,920,848 Public Shares exercised their right to redeem their shares for a pro
rata portion of the funds in the Trust Account. We paid cash in the aggregate amount of $40,298,391 (approximately $10.28 per Public Share)
to the redeeming stockholders.
The following table contains monthly information
about the repurchases of our equity securities for the three months ended September 30, 2023:
Period | |
(a) Total number
of shares
(or units)
purchased | | |
(b) Average
price paid
per share
(or unit) | | |
(c) Total number
of shares
(or units)
purchased as
part of publicly
announced plans
or programs | | |
(d) Maximum number
(or approximate
dollar value) of
shares (or units) that
may yet be purchased
under the plans or
programs | |
July 1 – July 31, 2023 | |
| — | | |
| — | | |
| — | | |
| — | |
| |
| | | |
| | | |
| | | |
| | |
August 1 – August 31, 2023 | |
| 3,920,848 | | |
$ | 10.28 | | |
| — | | |
| — | |
| |
| | | |
| | | |
| | | |
| | |
September 1 – September 30, 2023 | |
| — | | |
| — | | |
| — | | |
| — | |
ITEM 3. DEFAULTS UPON SENIOR SECURITIES.
None.
ITEM 4. MINE SAFETY DISCLOSURES.
Not applicable.
ITEM 5. OTHER INFORMATION.
None.
ITEM 6. EXHIBITS.
The following exhibits are filed as part of, or
incorporated by reference into, this report on Form 10-Q.
** |
Furnished herewith. |
|
|
(1) |
Incorporated herein by reference to the Company’s Current Report on Form 8-K filed with the SEC on August 24, 2023. |
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Dated: November 13, 2023 |
FINSERV ACQUISITION CORP. II |
|
|
|
By: |
/s/ Lee Einbinder |
|
|
Lee Einbinder |
|
|
Chief Executive Officer and Director |
|
|
(Principal Executive Officer) |
|
By: |
/s/ Steven Handwerker |
|
|
Steven Handwerker |
|
|
Chief Financial Officer |
|
|
(Principal Financial and Accounting Officer) |
26
30000000
30000000
3296904
9076870
0.00
0.05
0.08
0.14
8300000
8300000
8300000
8300000
0.00
0.05
0.08
0.14
0.00
0.00
0.05
0.05
0.08
0.08
0.14
0.14
false
--12-31
Q3
0001834336
0001834336
2023-01-01
2023-09-30
0001834336
fsrx:UnitsEachConsistingOfOneShareOfClassACommonStockAndOnequarterOfOneRedeemableWarrantMember
2023-01-01
2023-09-30
0001834336
us-gaap:CommonClassAMember
2023-01-01
2023-09-30
0001834336
fsrx:WarrantsEachExercisableForOneShareOfClassACommonStockFor1150PerShareMember
2023-01-01
2023-09-30
0001834336
us-gaap:CommonClassAMember
2023-11-13
0001834336
us-gaap:CommonClassBMember
2023-11-13
0001834336
2023-09-30
0001834336
2022-12-31
0001834336
us-gaap:RelatedPartyMember
2023-09-30
0001834336
us-gaap:RelatedPartyMember
2022-12-31
0001834336
us-gaap:CommonClassAMember
2023-09-30
0001834336
us-gaap:CommonClassAMember
2022-12-31
0001834336
us-gaap:CommonClassBMember
2023-09-30
0001834336
us-gaap:CommonClassBMember
2022-12-31
0001834336
2023-07-01
2023-09-30
0001834336
2022-07-01
2022-09-30
0001834336
2022-01-01
2022-09-30
0001834336
fsrx:RedeemableClassACommonStockMember
2023-07-01
2023-09-30
0001834336
fsrx:RedeemableClassACommonStockMember
2022-07-01
2022-09-30
0001834336
fsrx:RedeemableClassACommonStockMember
2023-01-01
2023-09-30
0001834336
fsrx:RedeemableClassACommonStockMember
2022-01-01
2022-09-30
0001834336
fsrx:NonredeemableClassAAndClassBCommonStockMember
2023-07-01
2023-09-30
0001834336
fsrx:NonredeemableClassAAndClassBCommonStockMember
2022-07-01
2022-09-30
0001834336
fsrx:NonredeemableClassAAndClassBCommonStockMember
2023-01-01
2023-09-30
0001834336
fsrx:NonredeemableClassAAndClassBCommonStockMember
2022-01-01
2022-09-30
0001834336
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2022-12-31
0001834336
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-12-31
0001834336
us-gaap:AdditionalPaidInCapitalMember
2022-12-31
0001834336
us-gaap:RetainedEarningsMember
2022-12-31
0001834336
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2023-01-01
2023-03-31
0001834336
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-01-01
2023-03-31
0001834336
us-gaap:AdditionalPaidInCapitalMember
2023-01-01
2023-03-31
0001834336
us-gaap:RetainedEarningsMember
2023-01-01
2023-03-31
0001834336
2023-01-01
2023-03-31
0001834336
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2023-03-31
0001834336
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-03-31
0001834336
us-gaap:AdditionalPaidInCapitalMember
2023-03-31
0001834336
us-gaap:RetainedEarningsMember
2023-03-31
0001834336
2023-03-31
0001834336
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2023-04-01
2023-06-30
0001834336
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-04-01
2023-06-30
0001834336
us-gaap:AdditionalPaidInCapitalMember
2023-04-01
2023-06-30
0001834336
us-gaap:RetainedEarningsMember
2023-04-01
2023-06-30
0001834336
2023-04-01
2023-06-30
0001834336
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2023-06-30
0001834336
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-06-30
0001834336
us-gaap:AdditionalPaidInCapitalMember
2023-06-30
0001834336
us-gaap:RetainedEarningsMember
2023-06-30
0001834336
2023-06-30
0001834336
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2023-07-01
2023-09-30
0001834336
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-07-01
2023-09-30
0001834336
us-gaap:AdditionalPaidInCapitalMember
2023-07-01
2023-09-30
0001834336
us-gaap:RetainedEarningsMember
2023-07-01
2023-09-30
0001834336
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2023-09-30
0001834336
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-09-30
0001834336
us-gaap:AdditionalPaidInCapitalMember
2023-09-30
0001834336
us-gaap:RetainedEarningsMember
2023-09-30
0001834336
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2021-12-31
0001834336
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2021-12-31
0001834336
us-gaap:AdditionalPaidInCapitalMember
2021-12-31
0001834336
us-gaap:RetainedEarningsMember
2021-12-31
0001834336
2021-12-31
0001834336
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2022-01-01
2022-03-31
0001834336
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-01-01
2022-03-31
0001834336
us-gaap:AdditionalPaidInCapitalMember
2022-01-01
2022-03-31
0001834336
us-gaap:RetainedEarningsMember
2022-01-01
2022-03-31
0001834336
2022-01-01
2022-03-31
0001834336
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2022-03-31
0001834336
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-03-31
0001834336
us-gaap:AdditionalPaidInCapitalMember
2022-03-31
0001834336
us-gaap:RetainedEarningsMember
2022-03-31
0001834336
2022-03-31
0001834336
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2022-04-01
2022-06-30
0001834336
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-04-01
2022-06-30
0001834336
us-gaap:AdditionalPaidInCapitalMember
2022-04-01
2022-06-30
0001834336
us-gaap:RetainedEarningsMember
2022-04-01
2022-06-30
0001834336
2022-04-01
2022-06-30
0001834336
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2022-06-30
0001834336
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-06-30
0001834336
us-gaap:AdditionalPaidInCapitalMember
2022-06-30
0001834336
us-gaap:RetainedEarningsMember
2022-06-30
0001834336
2022-06-30
0001834336
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2022-07-01
2022-09-30
0001834336
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-07-01
2022-09-30
0001834336
us-gaap:AdditionalPaidInCapitalMember
2022-07-01
2022-09-30
0001834336
us-gaap:RetainedEarningsMember
2022-07-01
2022-09-30
0001834336
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2022-09-30
0001834336
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-09-30
0001834336
us-gaap:AdditionalPaidInCapitalMember
2022-09-30
0001834336
us-gaap:RetainedEarningsMember
2022-09-30
0001834336
2022-09-30
0001834336
us-gaap:IPOMember
2021-02-22
2021-02-22
0001834336
us-gaap:OverAllotmentOptionMember
2021-02-22
2021-02-22
0001834336
us-gaap:OverAllotmentOptionMember
2021-02-22
0001834336
us-gaap:PrivatePlacementMember
2023-09-30
0001834336
us-gaap:PrivatePlacementMember
2023-01-01
2023-09-30
0001834336
us-gaap:IPOMember
2023-09-30
0001834336
us-gaap:IPOMember
2021-02-22
0001834336
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
2023-09-30
0001834336
fsrx:SecondExtensionMeetingMember
us-gaap:CommonClassAMember
2023-09-30
0001834336
fsrx:SecondExtensionMeetingMember
2023-01-01
2023-09-30
0001834336
fsrx:SecondExtensionMeetingMember
2023-09-30
0001834336
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
us-gaap:IPOMember
2023-09-30
0001834336
country:US
2023-01-01
2023-09-30
0001834336
us-gaap:CommonStockMember
2023-02-20
0001834336
2023-02-20
2023-02-20
0001834336
us-gaap:CommonStockMember
2023-02-20
0001834336
2021-01-01
2021-12-31
0001834336
2022-01-01
2022-12-31
0001834336
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
2023-01-01
2023-09-30
0001834336
fsrx:RedemptionOfWarrantsMember
us-gaap:CommonClassAMember
2023-01-01
2023-09-30
0001834336
fsrx:RedemptionOfWarrantsMember
2023-01-01
2023-09-30
0001834336
fsrx:RedemptionOfWarrantsMember
us-gaap:WarrantMember
2023-01-01
2023-09-30
0001834336
us-gaap:WarrantMember
2023-09-30
0001834336
us-gaap:PrivatePlacementMember
2022-12-31
0001834336
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
us-gaap:PrivatePlacementMember
2023-09-30
0001834336
fsrx:FounderSharesMember
2020-12-01
2020-12-31
0001834336
fsrx:FounderSharesMember
2020-12-31
0001834336
fsrx:FounderSharesMember
us-gaap:CommonClassBMember
2020-12-01
2020-12-31
0001834336
fsrx:FounderSharesMember
us-gaap:CommonClassBMember
2020-12-31
0001834336
fsrx:FounderSharesMember
us-gaap:CommonClassBMember
2021-02-01
2021-02-28
0001834336
us-gaap:OverAllotmentOptionMember
2021-02-28
0001834336
fsrx:FounderSharesMember
2021-02-01
2021-02-22
0001834336
fsrx:FounderSharesMember
us-gaap:CommonClassBMember
2021-02-01
2021-02-22
0001834336
us-gaap:CommonClassBMember
2023-01-01
2023-01-30
0001834336
us-gaap:IPOMember
2020-12-01
2020-12-23
0001834336
fsrx:SponsorMember
2023-08-22
0001834336
2023-08-22
0001834336
fsrx:WorkingCapitalLoanMember
2023-09-30
0001834336
2021-04-01
2021-04-01
0001834336
us-gaap:IPOMember
2023-01-01
2023-09-30
0001834336
2023-02-28
0001834336
2023-02-01
2023-02-20
0001834336
2023-02-20
0001834336
2023-08-01
2023-08-18
0001834336
fsrx:SecondExtensionMeetingMember
fsrx:PublicSharesMember
2023-01-01
2023-09-30
0001834336
us-gaap:CommonClassAMember
2023-01-01
2023-01-30
0001834336
us-gaap:CommonClassAMember
2023-02-20
0001834336
fsrx:CommonStockConversionMember
2023-01-01
2023-09-30
0001834336
us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember
2023-09-30
0001834336
us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember
us-gaap:FairValueInputsLevel1Member
2023-09-30
0001834336
us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember
us-gaap:FairValueInputsLevel2Member
2023-09-30
0001834336
us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember
us-gaap:FairValueInputsLevel3Member
2023-09-30
0001834336
fsrx:InvestmentsInMutualFundsMember
2023-09-30
0001834336
fsrx:InvestmentsInMutualFundsMember
us-gaap:FairValueInputsLevel1Member
2023-09-30
0001834336
fsrx:InvestmentsInMutualFundsMember
us-gaap:FairValueInputsLevel2Member
2023-09-30
0001834336
fsrx:InvestmentsInMutualFundsMember
us-gaap:FairValueInputsLevel3Member
2023-09-30
0001834336
us-gaap:FairValueInputsLevel1Member
2023-09-30
0001834336
us-gaap:FairValueInputsLevel2Member
2023-09-30
0001834336
us-gaap:FairValueInputsLevel3Member
2023-09-30
0001834336
fsrx:PublicWarrantsMember
2023-09-30
0001834336
us-gaap:FairValueInputsLevel1Member
fsrx:PublicWarrantsMember
2023-09-30
0001834336
us-gaap:FairValueInputsLevel2Member
fsrx:PublicWarrantsMember
2023-09-30
0001834336
us-gaap:FairValueInputsLevel3Member
fsrx:PublicWarrantsMember
2023-09-30
0001834336
us-gaap:FairValueInputsLevel1Member
us-gaap:PrivatePlacementMember
2023-09-30
0001834336
us-gaap:FairValueInputsLevel2Member
us-gaap:PrivatePlacementMember
2023-09-30
0001834336
us-gaap:FairValueInputsLevel3Member
us-gaap:PrivatePlacementMember
2023-09-30
0001834336
us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember
2022-12-31
0001834336
us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember
us-gaap:FairValueInputsLevel1Member
2022-12-31
0001834336
us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember
us-gaap:FairValueInputsLevel2Member
2022-12-31
0001834336
us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember
us-gaap:FairValueInputsLevel3Member
2022-12-31
0001834336
fsrx:InvestmentsInMutualFundsMember
2022-12-31
0001834336
fsrx:InvestmentsInMutualFundsMember
us-gaap:FairValueInputsLevel1Member
2022-12-31
0001834336
fsrx:InvestmentsInMutualFundsMember
us-gaap:FairValueInputsLevel2Member
2022-12-31
0001834336
fsrx:InvestmentsInMutualFundsMember
us-gaap:FairValueInputsLevel3Member
2022-12-31
0001834336
us-gaap:FairValueInputsLevel1Member
2022-12-31
0001834336
us-gaap:FairValueInputsLevel2Member
2022-12-31
0001834336
us-gaap:FairValueInputsLevel3Member
2022-12-31
0001834336
fsrx:PublicWarrantsMember
2022-12-31
0001834336
us-gaap:FairValueInputsLevel1Member
fsrx:PublicWarrantsMember
2022-12-31
0001834336
us-gaap:FairValueInputsLevel2Member
fsrx:PublicWarrantsMember
2022-12-31
0001834336
us-gaap:FairValueInputsLevel3Member
fsrx:PublicWarrantsMember
2022-12-31
0001834336
us-gaap:FairValueInputsLevel1Member
us-gaap:PrivatePlacementMember
2022-12-31
0001834336
us-gaap:FairValueInputsLevel2Member
us-gaap:PrivatePlacementMember
2022-12-31
0001834336
us-gaap:FairValueInputsLevel3Member
us-gaap:PrivatePlacementMember
2022-12-31
xbrli:shares
iso4217:USD
iso4217:USD
xbrli:shares
xbrli:pure
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
In connection with the Quarterly Report of FinServ
Acquisition Corp. II (the “Company”) on Form 10-Q for the quarterly period ended September 30, 2023, as filed with the Securities
and Exchange Commission on the date hereof (the “Report”), I, Lee Einbinder, Chief Executive Officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
In connection with the Quarterly Report of FinServ
Acquisition Corp. II (the “Company”) on Form 10-Q for the quarterly period ended September 30, 2023, as filed with the Securities
and Exchange Commission on the date hereof (the “Report”), I, Steven Handwerker, Chief Financial Officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge: